NRx Pharmaceuticals announces common stock offering, no amount given

NRx Pharmaceuticals announced that it intends to offer to sell shares of its common stock in an underwritten public offering of a limited number of shares. All of the shares of common stock are to be sold by the company. NRx Pharmaceuticals intends to use the net proceeds from the offering for working capital and general corporate purposes. The company may also use the net proceeds from the offering to repay certain outstanding debt. EF Hutton is acting as the sole book-running manager for the offering.